A U.S. government-sanctioned clinical trial for a coronavirus treatment is currently being conducted at a hospital in Wuhan, China. The trial aims to prove if Human Umbilical Cord Mesenchymal Stem Cells may be safe to use and treat patients with severe pneumonia of 2019-nCoV or COVID-19.
Basics of COVID-19
COVID-19 is considered a “new emerging respiratory infectious disease.” Patients who tested positive usually experience three common symptoms: fever, dry cough, and shortness of breath. While some patients have mild manifestations of the symptoms, those with severe cases may end up with a respiratory system failure that can be fatal.
As COVID-19 has no cure, biotechnology companies all over the world are rushing to develop a treatment for the pandemic which has claimed hundreds of thousands of lives. One such treatment that could be promising is through stem cell therapy.
Stem Cell Therapy for COVID-19 Patients
The idea behind stem cell therapy for treating coronavirus comes from old studies using mesenchymal stem cells (MSC). MSCs may promote the regeneration of damaged tissues, such as those in the lungs. Studies also show that MSCs could deliver anti-inflammatory outcomes that may help lung injuries recover.
However, this clinical trial is looking into using an umbilical cord MSCs (UC-MSCs), with its fast self-renewal properties and low immunogenicity. Early studies of UC-MSCs in mice show that it can work to reduce the severity of inflammation in the lungs.
The clinical trial, which was opened in February, has recruited 48 coronavirus patients with severe pneumonia due to COVID-19. Half of these patients received UC-MSCs treatments via a transfusion, which was facilitated for four times. The other half, which served as the control group, received conventional treatment.
Preliminary outcomes show that patients who received the stem cell therapy transfusion experienced a reduction in the size of their chest lesions and blood oxygen saturation at the baseline. Further evaluation is now being conducted within the next eight weeks to verify the efficiency of the treatment.
COVID-19 and stem cell therapy abroad
Meanwhile, there have been more than a dozen stem cell therapies for COVID-19 patients in China since the outbreak. One study in Beijing was on the successful treatment of a 65-year-old COVID-19 patient who received stem cell therapy.
She was given three shots of the stem cells and initially did not show any signs of improvement. Three days later, she was administered another shot and was able to get up for a walk from her bed with some help.
After her final stem cell therapy shot, the patient was out of the ICU within two days. Her vitals also improved and within a week of receiving stem cell therapy she tested negative for COVID-19.
Stem cell therapy in Colombia’s cost is very affordable. Learn more about us
If you are considering a stem cell therapy abroad and not sure where to go, our stem cell clinic, Colombia is a great place to consider. We offer less expensive and effective stem cell therapy outside the US for various medical cases and diseases. Our facility is equipped with the latest technologies and is manned by qualified staff and board-certified physicians.
We pride ourselves on the quality of our work and the trust we build and maintain with our patients. If you have any questions about stem cell therapy in Colombia, don’t hesitate to contact us and request pricing.
The material contained on this site is for informational purposes only and DOES NOT CONSTITUTE THE PROVIDING OF MEDICAL ADVICE, and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare providers with any questions or concerns you may have regarding your health.